4
Changes in Ownership
CytomX Therapeutics, Inc. Filed Acc 0001140361-17-017962
President and CEO sold 4,781 shares at $15.70 ($75,062)
- President and CEO acquired 4,781 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
McCarthy Sean A. · President and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-05-01 | Exercise or conversion : show line 1 in the form | +4,781 | $0.95 | $4,518 | 6,760 | D |
| 2017-05-01 | Sale : show line 2 in the form | −4,781 | $15.70 | $75,062 | 1,979 | D |
| Open-market sales · 4,781 sh · avg $15.70 · $75,062 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-05-01 | Exercise or conversion : show line 3 in the form Stock Option (right to buy) | −4,781 | 68,072 | D |
Loading xslF345X03/doc1.xml…